These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 12860778

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW, Rickels K, Sondheimer SJ, Polansky M.
    Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
    Suri RA, Altshuler LL, Rasgon NL, Calcagno JL, Frye MA, Gitlin MJ, Hwang S, Zuckerbrow-Miller J.
    J Clin Psychiatry; 2000 Dec; 61(12):942-6. PubMed ID: 11206600
    [Abstract] [Full Text] [Related]

  • 26. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.
    Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF, Goulart A, Boggio PS, Lotufo PA, Benseñor IM, Fregni F.
    JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323
    [Abstract] [Full Text] [Related]

  • 27. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
    Lewis G, Duffy L, Ades A, Amos R, Araya R, Brabyn S, Button KS, Churchill R, Derrick C, Dowrick C, Gilbody S, Fawsitt C, Hollingworth W, Jones V, Kendrick T, Kessler D, Kounali D, Khan N, Lanham P, Pervin J, Peters TJ, Riozzie D, Salaminios G, Thomas L, Welton NJ, Wiles N, Woodhouse R, Lewis G.
    Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
    [Abstract] [Full Text] [Related]

  • 28. Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study.
    Steinberg M, Munro CA, Samus Q, V Rabins P, Brandt J, Lyketsos CG.
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):144-50. PubMed ID: 14758580
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
    Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM.
    J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM.
    JAMA; 2000 Apr 12; 283(14):1837-44. PubMed ID: 10770145
    [Abstract] [Full Text] [Related]

  • 32. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
    Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ.
    J Clin Psychiatry; 1998 Dec 12; 59(12):669-75. PubMed ID: 9921701
    [Abstract] [Full Text] [Related]

  • 33. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
    Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR.
    Arch Gen Psychiatry; 2006 Mar 12; 63(3):283-8. PubMed ID: 16520433
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct 12; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
    Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM.
    Am J Psychiatry; 2004 Sep 12; 161(9):1642-9. PubMed ID: 15337655
    [Abstract] [Full Text] [Related]

  • 36. Design of Depression in Alzheimer's Disease Study-2.
    Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG.
    Am J Geriatr Psychiatry; 2006 Nov 12; 14(11):920-30. PubMed ID: 17068314
    [Abstract] [Full Text] [Related]

  • 37. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
    Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI.
    J Clin Psychiatry; 1999 May 12; 60(5):318-25. PubMed ID: 10362441
    [Abstract] [Full Text] [Related]

  • 38. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
    Newhouse PA, Krishnan KR, Doraiswamy PM, Richter EM, Batzar ED, Clary CM.
    J Clin Psychiatry; 2000 Aug 12; 61(8):559-68. PubMed ID: 10982198
    [Abstract] [Full Text] [Related]

  • 39. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 12; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 40. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.
    Arch Gen Psychiatry; 1999 Apr 12; 56(4):375-9. PubMed ID: 10197835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.